๐๏ธ Verified NIH Record โข Updated 2026-08-07
Pilot Study of Pancreatic Cancer Screening (NCT05058846)
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: University of California, San Francisco
๐ฉบ Plain-English Summary (8th-Grade Level)
This study investigates how often abnormal findings from routine magnetic resonance imaging occur in people with genetic mutations in BReast CAncer gene. (BRCA), ataxia telangiectasia mutated gene (ATM), or PALB2 screened for pancreatic cancer. This study may lead to a greater understanding of cancer and potentially, improvements in cancer screening and treatment.
Who can join: Review the eligibility criteria below.
Location: University of California San Francisco โ San Francisco, California
Age range: 18 Years
๐งช Interventions in This Study
- Biospecimen Collection (PROCEDURE)
- Magnetic Resonance Cholangiopancreatography (PROCEDURE)
- Magnetic Resonance Imaging (PROCEDURE)
- Endoscopic ultrasound (PROCEDURE)
- Questionnaires (OTHER)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of California San Francisco โ San Francisco, California
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pancreatic Carcinoma
- Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts โ Scottsdale, Arizona
- Use Of Indocyanine Green In Pancreas Surgery โ Portland, Oregon
- Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer โ Columbus, Ohio
- Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula โ Birmingham, Alabama
Explore by condition: All Pancreatic Carcinoma clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.